What are the characteristics of Hereditary Nonpolyposis Colorectal Cancer (HNPCC) or Lynch syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) Characteristics

Hereditary nonpolyposis colorectal cancer (HNPCC), also known as Lynch syndrome, is an autosomal dominant disorder that is strongly associated with a higher incidence of endometrial cancer. 1, 2

Genetic Basis

  • Lynch syndrome is caused by germline mutations in DNA mismatch repair (MMR) genes, including MLH1, MSH2, MSH6, PMS2, or deletions in the EPCAM gene 2, 3
  • MLH1 and MSH2 mutations account for >90% of Lynch syndrome families with known mutations 2
  • MSH6 mutations are responsible for approximately 5-10% of Lynch syndrome cases 2
  • The inheritance pattern is autosomal dominant, not recessive 1, 3

Cancer Risk Profile

  • Colorectal cancer: 22-80% lifetime risk (varies by specific gene mutation) 3
  • Endometrial cancer: 30-60% lifetime risk in women, making it the second most common cancer in Lynch syndrome 2, 3
  • Ovarian cancer: Increased risk, but lower than endometrial cancer risk 3
  • Other associated cancers include urinary tract, small intestine, gastric, pancreatic, biliary tract, and brain tumors 3

Colorectal Cancer Characteristics

  • Predominantly right-sided (proximal) colon cancers, with approximately 70% occurring proximal to the splenic flexure 1, 4
  • One-third of the cancers occur in the cecum 4
  • More rapid adenoma-to-carcinoma progression (approximately 35 months vs. 10-15 years in sporadic cases) 1, 3
  • Distinctive histopathological features including poor differentiation, signet cell histology, abundant extracellular mucin, tumor infiltrating lymphocytes, and lymphoid host response 1
  • Better stage-for-stage survival compared to sporadic colorectal cancer 3

Diagnostic Criteria

  • Amsterdam II criteria: Family history of 3 relatives with Lynch syndrome-associated cancer, with one being a first-degree relative of the other two, at least 2 successive generations affected, and at least 1 cancer diagnosed before age 50 3
  • Molecular diagnosis through identification of pathogenic germline mutations in MMR genes 1
  • Tumors demonstrate microsatellite instability (MSI) and loss of MMR protein expression on immunohistochemistry 2, 3

Management Implications

  • Colonoscopy every 1-2 years beginning in the 20s 3
  • Consider subtotal colectomy rather than segmental resection for initial colorectal cancer due to high risk of metachronous cancers 1, 4
  • Endometrial sampling and transvaginal ultrasound recommended annually for women starting at age 30-35 1
  • Prophylactic hysterectomy and oophorectomy have demonstrated efficacy 1

In summary, Lynch syndrome is an autosomal dominant disorder characterized by predominantly right-sided colorectal cancers and significantly increased risk of endometrial cancer, not left-sided colorectal cancers or autosomal recessive inheritance.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Gene Mutations Associated with Hereditary Non-Polyposis Colorectal Cancer (HNPCC)/Lynch Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Lynch Syndrome: A Genetic Predisposition to Multiple Cancers

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hereditary nonpolyposis colorectal cancer.

Seminars in surgical oncology, 2000

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.